Williams Jones Wealth Management, Llc. Regeneron Pharmaceuticals, Inc. Transaction History
Williams Jones Wealth Management, Llc.
- $7.94 Billion
- Q2 2024
A detailed history of Williams Jones Wealth Management, Llc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Williams Jones Wealth Management, Llc. holds 1,815 shares of REGN stock, worth $1.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,815
Previous 1,779
2.02%
Holding current value
$1.5 Million
Previous $1.71 Million
11.39%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding REGN
# of Institutions
1,492Shares Held
85.8MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$7.42 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.96 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$6.17 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.84MShares$3.99 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$3.82 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $88.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...